125 related articles for article (PubMed ID: 27233748)
1. Evaluation of a New Sonoclot Device for Heparin Management in Cardiac Surgery.
Dzemali O; Ganter MT; Zientara A; Graves K; Behr R; Genoni M; Hofer CK
Clin Appl Thromb Hemost; 2017 Jan; 23(1):20-26. PubMed ID: 27233748
[TBL] [Abstract][Full Text] [Related]
2. Monitoring activated clotting time for combined heparin and aprotinin application: in vivo evaluation of a new aprotinin-insensitive test using Sonoclot.
Ganter MT; Monn A; Tavakoli R; Genoni M; Klaghofer R; Furrer L; Honegger H; Hofer CK
Eur J Cardiothorac Surg; 2006 Aug; 30(2):278-84. PubMed ID: 16828293
[TBL] [Abstract][Full Text] [Related]
3. Viscoelastic blood coagulation measurement with Sonoclot predicts postoperative bleeding in cardiac surgery after heparin reversal.
Bischof DB; Ganter MT; Shore-Lesserson L; Hartnack S; Klaghofer R; Graves K; Genoni M; Hofer CK
J Cardiothorac Vasc Anesth; 2015; 29(3):715-22. PubMed ID: 25864405
[TBL] [Abstract][Full Text] [Related]
4. Effects of heparin, haemodilution and aprotinin on kaolin-based activated clotting time: in vitro comparison of two different point of care devices.
Dalbert S; Ganter MT; Furrer L; Klaghofer R; Zollinger A; Hofer CK
Acta Anaesthesiol Scand; 2006 Apr; 50(4):461-8. PubMed ID: 16548858
[TBL] [Abstract][Full Text] [Related]
5. Impact of Sonoclot hemostasis analysis after cardiopulmonary bypass on postoperative hemorrhage in cardiac surgery.
Yamada T; Katori N; Tanaka KA; Takeda J
J Anesth; 2007; 21(2):148-52. PubMed ID: 17458642
[TBL] [Abstract][Full Text] [Related]
6. Monitoring activated clotting time for combined heparin and aprotinin application: an in vitro evaluation of a new aprotinin-insensitive test using SONOCLOT.
Ganter MT; Dalbert S; Graves K; Klaghofer R; Zollinger A; Hofer CK
Anesth Analg; 2005 Aug; 101(2):308-314. PubMed ID: 16037133
[TBL] [Abstract][Full Text] [Related]
7. Kaolin-based activated coagulation time measured by sonoclot in patients undergoing cardiopulmonary bypass.
Ganter MT; Monn A; Tavakoli R; Klaghofer R; Zollinger A; Hofer CK
J Cardiothorac Vasc Anesth; 2007 Aug; 21(4):524-8. PubMed ID: 17678778
[TBL] [Abstract][Full Text] [Related]
8. The impact of heparin concentration and activated clotting time monitoring on blood conservation. A prospective, randomized evaluation in patients undergoing cardiac operation.
Despotis GJ; Joist JH; Hogue CW; Alsoufiev A; Kater K; Goodnough LT; Santoro SA; Spitznagel E; Rosenblum M; Lappas DG
J Thorac Cardiovasc Surg; 1995 Jul; 110(1):46-54. PubMed ID: 7609568
[TBL] [Abstract][Full Text] [Related]
9. Individualized heparin and protamine management improves rotational thromboelastometric parameters and postoperative hemostasis in valve surgery.
Vonk AB; Veerhoek D; van den Brom CE; van Barneveld LJ; Boer C
J Cardiothorac Vasc Anesth; 2014 Apr; 28(2):235-41. PubMed ID: 24342152
[TBL] [Abstract][Full Text] [Related]
10. In vivo and in vitro evaluation of the heparin management test versus the activated coagulation time for monitoring anticoagulation level in aprotinin-treated patients during cardiac surgery.
Kim YS; Murkin JM; Adams SJ
Heart Surg Forum; 2004; 7(6):E599-604. PubMed ID: 15769695
[TBL] [Abstract][Full Text] [Related]
11. The Hemochron Response RxDx heparin and protamine dosing system.
Jaryno SA; Zucker ML; LaDuca FM
J Extra Corpor Technol; 2004 Sep; 36(3):258-62. PubMed ID: 15559745
[TBL] [Abstract][Full Text] [Related]
12. A comparative analysis of four activated clotting time measurement devices in cardiac surgery with cardiopulmonary bypass.
Li H; Serrick C; Rao V; Yip PM
Perfusion; 2021 Sep; 36(6):610-619. PubMed ID: 32885714
[TBL] [Abstract][Full Text] [Related]
13. Platelet function monitoring with the Sonoclot analyzer after in vitro tirofiban and heparin administration.
Tucci MA; Ganter MT; Hamiel CR; Klaghofer R; Zollinger A; Hofer CK
J Thorac Cardiovasc Surg; 2006 Jun; 131(6):1314-22. PubMed ID: 16733164
[TBL] [Abstract][Full Text] [Related]
14. A Comparison of a New Ultrasound-Based Whole Blood Viscoelastic Test (SEER Sonorheometry) Versus Thromboelastography in Cardiac Surgery.
Reynolds PS; Middleton P; McCarthy H; Spiess BD
Anesth Analg; 2016 Dec; 123(6):1400-1407. PubMed ID: 27159065
[TBL] [Abstract][Full Text] [Related]
15. Hand-held personal digital assistant program for the HEMOCHRON RxDx heparin and protamine dosing system.
El Rouby S; Rinehart K; Zucker ML; LaDuca FM
J Extra Corpor Technol; 2003 Sep; 35(3):212-7. PubMed ID: 14653423
[TBL] [Abstract][Full Text] [Related]
16. FIBTEM PLUS provides an improved thromboelastometry test for measurement of fibrin-based clot quality in cardiac surgery patients.
Solomon C; Baryshnikova E; Schlimp CJ; Schöchl H; Asmis LM; Ranucci M
Anesth Analg; 2013 Nov; 117(5):1054-62. PubMed ID: 24108255
[TBL] [Abstract][Full Text] [Related]
17. The effects of MDCO-2010, a serine protease inhibitor, on activated clotting time in blood obtained from volunteers and cardiac surgical patients.
Kim H; Szlam F; Tanaka KA; van de Locht A; Ogawa S; Levy JH
Anesth Analg; 2012 Aug; 115(2):244-52. PubMed ID: 22584552
[TBL] [Abstract][Full Text] [Related]
18. Sonoclot coagulation analysis: new bedside monitoring for determination of the appropriate heparin dose during haemodialysis.
Furuhashi M; Ura N; Hasegawa K; Yoshida H; Tsuchihashi K; Miura T; Shimamoto K
Nephrol Dial Transplant; 2002 Aug; 17(8):1457-62. PubMed ID: 12147794
[TBL] [Abstract][Full Text] [Related]
19. Are the point-of-care diagnostics MULTIPLATE and ROTEM valid in the setting of high concentrations of heparin and its reversal with protamine?
Gertler R; Wiesner G; Tassani-Prell P; Braun SL; Martin K
J Cardiothorac Vasc Anesth; 2011 Dec; 25(6):981-6. PubMed ID: 21315618
[TBL] [Abstract][Full Text] [Related]
20. Point-of-Care Coagulation Testing in Cardiac Surgery.
Bolliger D; Tanaka KA
Semin Thromb Hemost; 2017 Jun; 43(4):386-396. PubMed ID: 28359133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
